{"schema_version":"secwatch.filing_event.v1","accession":"0000062709-25-000057","form_type":"8-K","ticker":"MRSH","cik":"0000062709","company_name":"MARSH & MCLENNAN COMPANIES, INC.","filed_at":"2025-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.151090+00:00","generated_at":"2026-05-18T08:59:08.675091+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Marsh McLennan appoints Bruce Broussard, former Humana CEO, to its Board of Directors","bullets":["Bruce Broussard, 63, appointed as independent director effective July 9, 2025; Board now has 12 directors.","He joins the Audit Committee, meeting independence and qualification requirements.","Broussard served as Humana CEO from 2013-2024 and previously as McKesson Specialty/US Oncology CEO.","He also serves on boards of HP Inc., Cleveland Clinic, and One Call."],"urls":{"canonical":"https://secwatch.observer/filing/0000062709-25-000057","json":"https://secwatch.observer/filing/0000062709-25-000057.json","markdown":"https://secwatch.observer/filing/0000062709-25-000057.md","text":"https://secwatch.observer/filing/0000062709-25-000057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/62709/000006270925000057/0000062709-25-000057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/62709/000006270925000057/mmc-20250709.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T08:59:08.675091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}